Brief introduction of Shanghai Edfa Pharmaceutical Co., Ltd.

From June 5, 2000 to 10, Shanghai Edfa Pharmaceutical Co., Ltd. obtained the first approval for the production of sustained-release pellets in the pharmaceutical history of China, which will fill the gap in the field of pellet release technology in China and mark that the pharmaceutical industry technology in China has entered a brand-new era.

200118 Shanghai Aifa Pharmaceutical Co., Ltd. obtained the GMP certificate issued by the State Administration of Pharmaceutical Products, indicating that Aifa has reached the excellent production management standard.

Shanghai Edfa Pharmaceutical Co., Ltd. aims to provide partners with high value-added products, so as to prolong the life cycle of drugs, improve the compliance of patients and the curative effect of drugs, reduce toxic and side effects, and thus improve the clinical application prospects of drugs.